Source:http://linkedlifedata.com/resource/pubmed/id/16151260
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-9-9
|
pubmed:abstractText |
Antiangiogenic activity of curcumin on the tumor neogenesis was investigated by evaluating the density of neocapillaries induced by Hepatocellular carcinoma cells (HepG2) in mice, using intravital fluorescence videomicroscopy. Male BALB/c nude mice (20-25 g) were used, and a dorsal skin-fold chamber was implanted. HepG2 (30 microl of 2 x 10(6) cells) were inoculated on the upper surface of the skin within the chamber. The mice were divided into two groups as follows. Dimethyl sulfoxide solution (0.1%) was fed (HepG2 group, n=5) or curcumin solution (3000 mg/kg bw) was fed oral daily (HepG2-Cur group, n=5), one day after the inoculation of HepG. On days 7 and 14 post-tumor-inoculation, the tumor microvasculature was visualized by injecting 0.1 ml of 0.5% rhodamine B isothiocyanate-labeled dextran intravenously, and observed under an intravital fluorescence videomicroscope. Based on the recorded videoimage, the tumor neocapillary density and microvasculature were evaluated using a digital image analysis and correlated with the tumor area. The image analysis demonstrated that in the HepG2-group the neocapillary densities were significantly increased on day 7, and day 14, compared to the aged-matched Sham-group (P<0.05). In the HepG2-Cur group, the increase of tumor neocapillary density was attenuated significantly. It was suggested that high dose of curcumin might be an effective anti-angiogenic drug in the treatment against tumor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1386-0291
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
127-35
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16151260-Angiogenesis Inhibitors,
pubmed-meshheading:16151260-Animals,
pubmed-meshheading:16151260-Carcinoma, Hepatocellular,
pubmed-meshheading:16151260-Curcumin,
pubmed-meshheading:16151260-Drug Evaluation, Preclinical,
pubmed-meshheading:16151260-Humans,
pubmed-meshheading:16151260-Male,
pubmed-meshheading:16151260-Mice,
pubmed-meshheading:16151260-Mice, Nude,
pubmed-meshheading:16151260-Microscopy, Video,
pubmed-meshheading:16151260-Neoplasm Transplantation,
pubmed-meshheading:16151260-Neovascularization, Pathologic,
pubmed-meshheading:16151260-Transplantation, Heterologous
|
pubmed:year |
2005
|
pubmed:articleTitle |
Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice.
|
pubmed:affiliation |
Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|